...
首页> 外文期刊>AIDS Research and Human Retroviruses >Short communication: Analysis of the integrase gene from HIV type 1-positive patients living in a rural area of west cameroon
【24h】

Short communication: Analysis of the integrase gene from HIV type 1-positive patients living in a rural area of west cameroon

机译:简短交流:居住在西喀麦隆农村地区的HIV 1型阳性患者的整合酶基因分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Major mutations associated with HIV-I integrase inhibitors (INI) resistance are rare in INI-naive patients. However, polymorphisms at positions that may influence the genetic barrier and/or drive the selection of specific INI resistance pathways are common in HIV non-B subtypes. The aim was to evaluate the presence of natural polymorphisms and/or INI resistance mutations in HIV-1 non-B subtype samples obtained from INI-naive patients living in rural west Cameroon. Thirty-three HIV-1 non-B samples were obtained from INI-naive African women and, as controls, 15 samples of HIV-1 subtype B were obtained from antiretroviral-naive Italian patients. The integrase gene was amplified and sequenced using Trugene Core Reagents. Several amino acid positions in B and non-B subtypes were found to be polymorphic. Interestingly, two patients infected with the CRF02-AG subtype had the resistance mutations N155H and E157Q/E and 12% of African samples had an amino acid substitution at position 143. Silent mutations leading to a higher increment of genetic barriers were detected at 140 and 151 positions in non B-subtypes. Although most polymorphisms may have little effect on INI susceptibility, the IN gene variations found in the present study should be taken into consideration as they may facilitate or delay the emergence of variants fully resistant to INIs.
机译:与HIV-1整合酶抑制剂(INI)抗药性相关的主要突变在未使用INI的患者中很少见。但是,在可能影响遗传屏障和/或驱动特定INI抗性途径选择的位置上的多态性在HIV非B亚型中很常见。目的是评估从居住在喀麦隆西部农村的INI初治患者中获得的HIV-1非B亚型样本中自然多态性和/或INI抗性突变的存在。从INI初免的非洲妇女中获得了33个HIV-1非B样本,作为对照,从抗逆转录病毒的初次意大利患者中获得了15个HIV-1 B型样本。使用Trugene Core Reagents扩增整合酶基因并测序。发现B和非B亚型中的几个氨基酸位置是多态的。有趣的是,两名感染了CRF02-AG亚型的患者的抗药性突变为N155H和E157Q / E,非洲样本中有12%的患者在143位有一个氨基酸取代。在140和140℃检测到沉默突变,导致更高的遗传障碍增量。非B亚型的151个位置。尽管大多数多态性可能对INI敏感性几乎没有影响,但应考虑本研究中发现的IN基因变异,因为它们可能促进或延迟对INI产生完全抗性的变异的出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号